Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

TNFRSF18/GITR/CD357 Antibody

" in MedChemExpress (MCE) Product Catalog:

By Targets:	NF-κB (1) TNF Receptor (3)
By Research Areas:	Cancer (3) Inflammation/Immunology (1)

Inhibitors & Agonists

Inhibitory Antibodies

Antibodies

AMG-228	TNF Receptor	Cancer
AMG-228 is a human IgG1 monoclonal antibody (mAb) targeting *TNFRSF18/GITR/CD357*. AMG-228 can be used in advanced solid tumors research .

IBI37G5	TNF Receptor	Cancer
IBI37G5 is a human monoclonal antibody (mAb) targeting *TNFRSF18/GITR/CD357. IBI37G5 has anti*-tumor activity in MC38 and B16F10 mouse tumor models. IBI37G5 can be used in the study of cancer immunity .

FPA154 INBRX-110	TNF Receptor NF-κB	Cancer
FPA154 is a human monoclonal antibody against *TNFRSF18/GITR/CD357. FPA154 activates NF-κB* via the GITR pathway. FPA154 can be used in solid tumor research. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .

Cat. No.	Product Name	Target	Research Area	Image

HY-P990525

Anti-TNFRSF18/GITR/CD357 Antibody	Inhibitory Antibodies	Inflammation/Immunology
The Anti-TNFRSF18/GITR/CD357 Antibody is a CHO-expressed human antibody targeting *TNFRSF18/GITR/CD357. The Anti-TNFRSF18/GITR/CD357* Antibody features a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-TNFRSF18/GITR/CD357 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991404

AMG-228	TNF Receptor	Cancer
AMG-228 is a human IgG1 monoclonal antibody (mAb) targeting *TNFRSF18/GITR/CD357*. AMG-228 can be used in advanced solid tumors research .

HY-P991464

IBI37G5	TNF Receptor	Cancer
IBI37G5 is a human monoclonal antibody (mAb) targeting *TNFRSF18/GITR/CD357. IBI37G5 has anti*-tumor activity in MC38 and B16F10 mouse tumor models. IBI37G5 can be used in the study of cancer immunity .

HY-P992354

FPA154 INBRX-110	TNF Receptor NF-κB	Cancer
FPA154 is a human monoclonal antibody against *TNFRSF18/GITR/CD357. FPA154 activates NF-κB* via the GITR pathway. FPA154 can be used in solid tumor research. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .

Host:	Mouse (2) Rabbit (1)
Reactivity:	Human (3)
Application:	IHC-P (2) FC (3) ELISA (3)
Isotype:	IgG (1) IgG1 (2)
Conjugation:	Non-conjugated (3)
Clonality:	Monoclonal (2) Recombinant (1)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81588

	GITR Antibody (YA1333) AITR; GITR; TNFRSF18; CD357	FC, ELISA	Human
	GITR Antibody (YA1333) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to GITR.

HY-P84896

	TNFRSF18 Antibody (YA4593) AITR; GITR; CD357; GITR-D	IHC-P, FC, ELISA	Human
	TNFRSF18 Antibody (YA4593) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TNFRSF18.

HY-P84896A

	TNFRSF18 Antibody (YA4593)(PBS only) AITR; GITR; CD357; GITR-D	IHC-P, FC, ELISA	Human
	TNFRSF18 Antibody (YA4593) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TNFRSF18.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy

Name
Email *

	Sorry, but the email address you supplied was invalid.